The purpose of this study is to identify and evaluate oral fluid testing as a biologic measure of cannabis use days that can be assessed remotely. The researchers will conduct this fully virtual study among a community sample of 200 individuals aged 18-30 years who have used cannabis at least 1 time per week on average in the past 30 days. Participants will complete oral fluid (saliva) tests, urine tests, and Timeline Follow-back interviews (self-report) that indicate their recent cannabis use (delta-9-THC). Participants will present for 3 virtual study visits across \~3-4 weeks and be asked to complete activities in between: Study Visit 1 (Day 0; informed consent, baseline survey, TLFB interview), Study Visit 2 (\~Day 7; TLFB interview, urine testing), 6 days of at-home videorecorded oral fluid testing, Study Visit 3 (\~Day 21; TLFB interview, urine test, oral fluid test, survey, interview).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Testing duration: self-testing
Timeframe: Across 6 days leading up to the Day-21 visit
Testing duration: observed test
Timeframe: Day of/During the Day-21 visit
Oral fluid testing protocol adherence: self-testing completed
Timeframe: Across 6 days leading up to the Day-21 visit
Oral fluid testing protocol adherence: observed test completed
Timeframe: Day of/During the Day-21 visit
Oral fluid testing protocol adherence: testing steps performed
Timeframe: Across 6 days leading up to the Day-21 visit; Day of/During the Day-21 visit
Oral fluid testing protocol adherence: testing steps performed correctly
Timeframe: Across 6 days leading up to the Day-21 visit; Day of/During the Day-21 visit
Unreadable test results
Timeframe: Across 6 days leading up to the Day-21 visit; Day of/During the Day-21 visit
Inconclusive test results
Timeframe: Across 6 days leading up to the Day-21 visit; Day of/During the Day-21 visit
Oral fluid test results
Timeframe: Across 6 days leading up to the Day-21 visit; Day of/During the Day-21 visit
Oral fluid acceptability
Timeframe: Day-21 visit
Use/Non-use intervals of 4 days
Timeframe: Across 6 days leading up to the Day-21 visit; Day of/During the Day-21 visit
Use/Non-use
Timeframe: Day-21 visit